Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

US Patent 9732140 · Granted Aug 15, 2017

Estimated economic value: $379,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant CD83 promoter and use thereof2017
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Soluble CD83 proteins and use thereof for the treatment and prevention of a dise2012
Soluble CD83 proteins and use thereof for the treatment and prevention of a dise2012
Soluble CD83 proteins and use thereof for the treatment and prevention of a dise2012
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2011
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2011